Ede Ronald Hao Xi

The trades of Ede Ronald Hao Xi at Innovent Biologics, Inc., a company listed on the Hong Kong stock exchange, run from October 31, 2018 to September 1, 2026, in 22 filings. The title recorded is Director. The record holds 9 purchases, 8 sales and 5 filings of another kind, so purchases are 53% of market trades.

The 8 sales come to EUR 104,477,991, with a median of EUR 9,373,424. The three largest are EUR 40,161,696 on July 22, 2021, EUR 18,390,228 on July 3, 2026 and EUR 14,517,593 on January 21, 2021.

The year 2026 holds 8 filings, more than any other. Those eight filings are also those of the last twelve months: 2 purchases and 4 sales. Filings are published a median of 5 days after the trade, across 22 dated filings.

Xi's own market trades within 30 days of colleagues at Innovent Biologics, Inc. number 13, 11 and 10. Of which in the same direction: 11, 8 and 8. Names in order: Yu De-Chao Michael, Cooney Charles Leland and Hsu Joyce I-Yin.